Authors are invited to contribute under the scope that is defined as “Phage therapeutics and its implications in controlling the infectious diseases”. The submissions should clearly demonstrate the potentials/ or challenges of phage modalities via, original research (Phage Drug Development, Experimental Studies, Pharmacodynamic and Pharmacokinetic Studies, Preclinical, Clinical trials, Pilot studies, etc.), reviews, perspectives, technical reports and case studies particularly focusing on the application of phages in therapeutics. We propose the following vital themes:

  • Microbial Synthesis of phage drugs and nanoparticles to fight against MDR pathogens.
  • MDR infections to treat with phage drugs- Experimental/ or Pre clinical and clinical studies.
  • Phage and Antibiotics’ Synergy
  • Phage -host relationships and linked immunological response to combat antibiotic resistance.
  • Antimicrobial applications of phages to control the nosocomial MDR infections.
  • The role microbiome plus phages to control the bacterial infection.

SUBMIT THE ABSTRACT BEFORE 24 JULY 2024

FINAL MANUSCRIPT TO BE SUBMITTED BEFORE 11 NOVEMBER 2024

You can access the Project's Public Page as below: https://www.frontiersin.org/research-topics/63638/emerging-trends-in-phage-therapeutics-to-overcome-antibiotic-resistance

If you need any assistance, then please forward you query.

PLEASE SHARE THIS POST TO YOUR NETWORK TOO

More Anju Kaushal's questions See All
Similar questions and discussions